跳至主要内容
临床试验/JPRN-UMIN000015338
JPRN-UMIN000015338已完成未知

Effects of a lactic acid bacteria beverage on bowel movement and intestinal microflora: double blind, placebo-controlled study - Effects of a lactic acid bacteria beverage on bowel movement and intestinal microflora

TTC Co., Ltd.0 个研究点目标入组 60 人开始时间: 2014年10月3日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 64years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Subjects regularly using drugs (constipation drugs, intestinal drugs, etc.) , health foods (senna tea, kefir, etc.), or foods for specified health use (indigestible dextrin, chitosan, oligosaccharides, etc.) (2) Subjects having a large amount of foods such as lactic acid bacteria beverage, food containing lactic acid bacteria (yogurt, kimchi, pickles, sushi fermented with fish and vegetables, etc.), lactic acid bacteria preparation, dietary fiber enriched food, and oligosaccharides more than three times a week (3) Subjects visiting the hospital for diseases related bowel movements and using drugs, or using commercial laxative (4) Subjects currently undergoing treatment with digestive diseases that affect the study or having a surgical history of digestive system (except appendicectomy) (5) Subjects having diseases (irritable enteritis, ulcerative colitis, etc.) affecting bowel movement or a history of these diseases (6) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (7) Subjects judged as unsuitable for this study based on the results of clinical examination or cardiopulmonary abnormality (8) Subjects having possibilities for emerging allergy related to the study (9) Subjects having a disease requiring regular medication or a history of serious diseases for which medication was required (10) Subjects who have participated in other clinical studies (11) Subjects who intend to become pregnant or lactating (12) Subjects judged as unsuitable for the study by physician for other reasons

研究者

发起方
TTC Co., Ltd.

相似试验